Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Researchers have found in a new real-world study that dupilumab was an effective and safe therapeutic option for head and ...

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...

On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

Please provide your email address to receive an email when new articles are posted on . 40% to 50% of patients with chronic hand eczema have concomitant atopic dermatitis. Differentially expressed ...

And the most recent article came out of JAMA in 2024, and they found that for every 1 g increase in urinary sodium, you ...

In 2025, the most-read Healio story on skin disorders was about the impact dietary diversity during pregnancy has on the risk ...

A review indicates that probiotic, prebiotic, and synbiotic supplements could be beneficial for skin health, especially for ...